First, they show that human nasal carriage can boost innate (alveolar macrophage function) and adaptive (TNF+IL-17A+ CD4+ memory T-cells) cellular lung immunity that may protect the lung from pneumococcal challenge and the establishment of infection in health, without significant recruitment of neutrophils. Here, IL17A is linked to infection.